An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion

Conclude your understanding of lymphoma with an in-depth look at its signs and symptoms, from common indicators to subtle clues.

Speaker : Dr Suvir Singh

Redefining Treatment Pathways in Relapsed/Refractory Adult B-Cell ALL

Discover groundbreaking treatments offering new hope for adults with relapsed B-cell ALL. Explore the latest advances, therapies, and strategies transforming outcomes in this challenging leukemia.

Speakers : Dr Riyaz Ahmed ,Dr Isha Kaul ,Dr Nitin Gupta

Understanding Early Relapse in B-cell ALL: Rates, Risks, and Common Sites

Learn about early relapse in B-cell ALL, including relapse rates within the first year, key risk factors, and the most common sites like bone marrow and CNS.

Speakers : Dr Nitin Gupta ,Dr Isha Kaul ,Dr Riyaz Ahmed

From Relapse to Remission: Mapping the Treatment Journey in Adult R/R-Cell ALL - Part 2

Explore optimal first-salvage therapies for adult R/R B-Cell ALL with high disease burden, advancing remission and personalized treatment.

Speakers : Dr Nitin Gupta ,Dr Isha Kaul ,Dr Riyaz Ahmed

From Relapse to Remission : Chasing the Invisible and Redefining Long-Term Survival in Adult R/R B-Cell ALL

Exploring novel therapies and redefining long-term survival outcomes in adult relapsed/refractory B-cell ALL through precision and immunotherapy.

Speakers : Dr Nitin Gupta ,Dr Isha Kaul ,Dr Riyaz Ahmed

Exploring the Hospitalization Burden in Refractory and Relapsed ALL

Explore the hospitalization burden, healthcare impact, and resource demands in patients with relapsed or refractory acute lymphoblastic leukemia (ALL).

Speakers : Dr Nitin Gupta ,Dr Isha Kaul ,Dr Riyaz Ahmed

Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial

Explore the revolutionary potential of Lorlatinib, a third-generation ALK-TKI, through the CROWN trial with Dr. Vamshi Krishna M.

Speakers : Dr. Vamsi Krishna M

Incidence of Lung Cancer- An Overview to Understand ALK Rearranged NSCLC

Explore the incidence of lung cancer and key insights into ALK-rearranged NSCLC with Dr. Vamshi Krishna M. Learn about diagnosis, targeted therapies, and advancements in treatment.

Speakers : Dr. Vamsi Krishna M

Unmet Needs in ALK Positive NSCLC- The Challenges in the Current Care

Explore the unmet needs in ALK-positive NSCLC with Dr. Vamshi Krishna M as he discusses current challenges, treatment gaps, and future directions in lung cancer care.

Speakers : Dr. Vamsi Krishna M

Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC

Explore the potential of lorlatinib as first-line therapy for ALK+ NSCLC with Dr. Vamshi Krishna M. Learn about efficacy, safety, guideline recommendations, and its role in improving patient outcomes.

Speakers : Dr. Vamshi Krishna M

Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)

In this webinar, a detailed discussion is done on Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)

Speakers : Dr. Sushant Mittal - Moderator ,Dr. Randeep Singh - Panelist ,Dr. Tarachand Gupta - Panelist ,Dr. Davinder Paul - Panelist


Recommended News For You

Muscle Strength, Fitness Linked to Lower Mortality Risk in Patients With Cancer

According to JAMA, statin use may increase cancer-related survival in breast cancer patients.

Immunotherapy-TACE Regimen Boosts PFS in Unresectable Liver Cancer

Males with early-onset colorectal cancer are at risk, according to a study.

Trump Issues Gag Order for CDC, FDA; Stalled Hearing for RFK Jr.; Sex After Cancer

Alcohol Causes Cancer. We Should Be Drinking Less.

Getting ahead of head and neck cancer

Recommended Articles For You

Practical Concepts in Hematology and Patient Outcomes 

Innovative Bioengineering Approaches for Erectile Function Recovery After Radical Prostatectomy 

Clinical Pharmacology of Iron Homeostasis Regulatory Therapeutics 

Does Lactate Signal Anemia? Exploring the Complexities of Hyperlactatemia and Red Blood Cell Health 
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Study opens up possibility of bespoke prostate cancer treatment

2.

Why Encouragement May Not Improve Motivation in Depression

3.

Study Finds Actionable Mutations in Brain Mets of Breast Cancer Patients

4.

A person's susceptibility to papillary thyroid cancer may be determined by variations in telomere lengthening genes.

5.

Pirtobrutinib May Be Beneficial in Follicular Lymphoma with Severe Pretreatment.

1.

Prevention Through Survivorship-Focused Strategies for Preserving Functional Independence After Cancer

2.

Patient Management for Bone Marrow Functional Recovery Pathways

3.

Uncovering the Causes of Thrombocytosis: A Journey to Improved Health

4.

Targeted Approaches to Breast Cancer Liver Metastases: Surgery, Ablation, and Survival Insights

5.

Hematopoietic Immune Microenvironment Plasticity: Mechanisms, Clinical Implications, and Emerging Therapeutics

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V

2.

Virtual Case Study on Elephantiasis of Lower Limb- An Initiative by Hidoc Dr.

3.

Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part IV

4.

Early Cancer Detection Saves Lives

5.

How Platelet Disorders Can Affect the Body

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot